HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 80 filers reported holding HARROW HEALTH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,151,497 | -28.8% | 80,132 | -5.7% | 0.00% | – |
| Q2 2023 | $1,617,410 | +66.1% | 84,948 | +84.5% | 0.00% | – |
| Q1 2023 | $973,995 | -35.9% | 46,030 | -55.3% | 0.00% | – |
| Q4 2022 | $1,518,893 | +0.7% | 102,906 | -17.7% | 0.00% | -100.0% |
| Q3 2022 | $1,509,000 | +65.8% | 124,962 | 0.0% | 0.00% | – |
| Q2 2022 | $910,000 | +6.7% | 124,962 | 0.0% | 0.00% | – |
| Q1 2022 | $853,000 | -21.0% | 124,962 | 0.0% | 0.00% | – |
| Q4 2021 | $1,080,000 | -4.9% | 124,962 | 0.0% | 0.00% | – |
| Q3 2021 | $1,136,000 | -2.2% | 124,962 | 0.0% | 0.00% | – |
| Q2 2021 | $1,161,000 | +208.8% | 124,962 | +124.5% | 0.00% | – |
| Q1 2021 | $376,000 | -1.6% | 55,666 | 0.0% | 0.00% | – |
| Q4 2020 | $382,000 | +30.8% | 55,666 | +6.9% | 0.00% | – |
| Q3 2020 | $292,000 | +1.7% | 52,060 | -5.4% | 0.00% | – |
| Q2 2020 | $287,000 | – | 55,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,140,000 | $29,171,000 | 4.84% |
| Ophir Asset Management Pty Ltd | 1,670,817 | $15,522,000 | 2.73% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 378,389 | $3,515,000 | 1.16% |
| Birchview Capital, LP | 180,000 | $1,672,000 | 1.00% |
| Diametric Capital, LP | 82,443 | $766,000 | 0.55% |
| Precision Wealth Strategies, LLC | 65,530 | $609,000 | 0.52% |
| Uniplan Investment Counsel, Inc. | 507,602 | $4,715,000 | 0.28% |
| BARD ASSOCIATES INC | 86,315 | $802,000 | 0.26% |
| EAM Investors, LLC | 142,272 | $1,322,000 | 0.20% |
| Zebra Capital Management LLC | 15,786 | $147,000 | 0.17% |